Sutureless Conjunctiva-Sparing Müllerectomy Is Promising
WEDNESDAY, July 5, 2023 (HealthDay News) -- Sutureless conjunctiva-sparing Müllerectomy (CSM) surgery is a promising technique for mild-to-moderate blepharoptosis, with good long-term outcomes, according to a study published in the July issue of the American Journal of Ophthalmology.
Ronald Mancini, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues describe a novel sutureless CSM surgery using medical records of 100 patients undergoing posterior ptosis repair surgery, with a minimum follow-up interval of six months. Outcome measures were assessed from margin reflex distance 1 (MRD1) and palpebral fissure height (PFH) at various time points after surgery.
The researchers found that at six months, the mean change in MRD1 and PFH was 2.85 ± 0.98 mm and 2.60 ± 1.38 mm, respectively. In 91 percent of cases, there was symmetry within 1 mm. On average, sutureless CSM took 4.42 minutes, compared with 8.45 minutes for traditional Müller muscle-conjunctival resection. No corneal abrasions or ocular complications were seen. There was a 2.3 percent reoperation rate per eye.
"Our study found that sutureless CSM is highly effective," Mancini said in a statement. "Only 2.3 percent of the patients studied required a second surgery for either undercorrection or overcorrection, and none of the patients experienced a postoperative corneal abrasion or ocular complication."
Related Posts
La metformina, un medicamento para la diabetes, podría evitar la COVID grave
MIÉRCOLES, 23 de noviembre de 2022 (HealthDay News) -- Un medicamento para la...
AHA News: Blood Vessels – Not Just Brain Cells – Can Affect Brain Health, New Report Finds
MONDAY, April 3, 2023 (American Heart Association News) -- Brain cells have a...
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important...
Una corte de apelaciones restaura la obligatoriedad de las vacunas para los trabajadores federales
VIERNES, 8 de abril de 2022 (HealthDay News) -- Una corte de apelaciones federal...